Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
News|Articles|April 16, 2020
ISTA Seeks Industry Feedback on Thermal Packaging Guideline
Author(s)Pharmaceutical Technology Editors
The International Safe Transit Association’s Pharma Committee published a guideline on the passive thermal packaging qualification process.
Advertisement
The International Safe Transit Association (ISTA) Pharma Committee is looking for feedback from the life-science’s industry on a technical paper that offers a guideline for the passive thermal packaging operational qualification process. The guideline, which is the result of a collaborative effort between life-science companies and suppliers, defines minimum requirements and aims to drive standardization for packaging providers and life-science companies.
ISTA says that the guideline will simplify comparison, ensure that solutions meet testing and quality expectations, enable further innovation by making expectations clear, and streamline the review process. Although other guidelines exist, according to the March 26, 2020 press release, the committee aims “to provide users with a how-to guide to achieve success on important industry topics while allowing users to work within their own internal procedures. We believe the level of detail beyond the suggested industry best practice is the decision of the primary stakeholders of the temperature-sensitive product and based on each organization's risk acceptance.”
ISTA’s deadline for comments is April 30, 2020.
Source:
Advertisement
Related to this article
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Advertisement
Advertisement